Response to Letter to the Editor by Bartoloni et al: 'Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndrome'

J Intern Med. 2020 Feb;287(2):216-217. doi: 10.1111/joim.12996. Epub 2019 Nov 5.

Authors

J Mofors¹, M Wahren-Herlenius¹, G Nordmark²

Affiliations

¹ Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
² Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

PMID: 31631437
DOI: 10.1111/joim.12996

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Cardiovascular Diseases*
Cerebral Infarction
Humans
Hypertension*
Risk Factors
Sjogren's Syndrome*
Venous Thromboembolism*

Substances

Biomarkers